- Home
- PAX vs ARQT Comparison
PAX vs ARQT Comparison
Compare PAX & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAX
- ARQT
- Stock Information
- Founded
- PAX 1988
- ARQT 2016
- Country
- PAX Cayman Islands
- ARQT United States
- Employees
- PAX N/A
- ARQT N/A
- Industry
- PAX Investment Managers
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- PAX Finance
- ARQT Health Care
- Exchange
- PAX Nasdaq
- ARQT Nasdaq
- Market Cap
- PAX 2.1B
- ARQT 1.7B
- IPO Year
- PAX 2021
- ARQT 2020
- Fundamental
- Price
- PAX $13.87
- ARQT $13.82
- Analyst Decision
- PAX Strong Buy
- ARQT Strong Buy
- Analyst Count
- PAX 1
- ARQT 6
- Target Price
- PAX $14.00
- ARQT $18.80
- AVG Volume (30 Days)
- PAX 634.8K
- ARQT 1.9M
- Earning Date
- PAX 07-31-2025
- ARQT 08-13-2025
- Dividend Yield
- PAX 4.33%
- ARQT N/A
- EPS Growth
- PAX N/A
- ARQT N/A
- EPS
- PAX 0.45
- ARQT N/A
- Revenue
- PAX $389,900,000.00
- ARQT $212,819,000.00
- Revenue This Year
- PAX $5.53
- ARQT $61.15
- Revenue Next Year
- PAX N/A
- ARQT $37.98
- P/E Ratio
- PAX $30.58
- ARQT N/A
- Revenue Growth
- PAX 22.70
- ARQT 100.03
- 52 Week Low
- PAX $9.43
- ARQT $7.86
- 52 Week High
- PAX $14.12
- ARQT $17.75
- Technical
- Relative Strength Index (RSI)
- PAX 66.42
- ARQT 50.73
- Support Level
- PAX $13.65
- ARQT $12.97
- Resistance Level
- PAX $14.02
- ARQT $13.84
- Average True Range (ATR)
- PAX 0.28
- ARQT 0.61
- MACD
- PAX -0.01
- ARQT 0.02
- Stochastic Oscillator
- PAX 84.24
- ARQT 51.64
About PAX Patria Investments Limited
Patria Investments Ltd is an alternative asset management firm specializing in resilient sectors across select regions. It seeks to provide world-wide and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns. The group promotes inclusive and sustainable development in the Asset Classes: Private Equity, Private Equity Solutions, Credit, Real Estate, Infrastructure, and Public Equities Main sectors: Agribusiness, Power & Energy, Healthcare, Logistics & Transportations, Food & Beverage and Digital & Tech Services Investment Regions.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.